Cart
sales@molnova.com
Linzagolix choline
CAS No. 1321816-57-2
Linzagolix choline( —— )
Catalog No. M34100 CAS No. 1321816-57-2
Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 276 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 50MG | 830 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | 1479 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinzagolix choline
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
-
DescriptionLinzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGNRH Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1321816-57-2
-
Formula Weight611.59
-
Molecular FormulaC27H28F3N3O8S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([O-])C=1SC=C2NC(=O)N(C(=O)C21)C=3C=C(OCC4=C(F)C(F)=CC=C4OC)C(OC)=CC3F.OCC[N+](C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Betmidin
Betmidin is a natural product for research related to life sciences.
-
Deruxtecan
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
-
SQ109
SQ109 is an effective inhibitor of the trypomastigote form of the parasite (IC50 = 50 nM). SQ109 is an antitubercular agent and targets MmpL3.
